Are neurohumoral parameters predictive for the efficacy of cardiac resynchronization therapy? - The role of natriuretic peptides;Sind neurohumorale blutparameter wegweisend für die effizienz der kardialen resynchronisationstherapie? - Die rolle der natriuretischen peptide

Herzschrittmachertherapie und Elektrophysiologie

Volumn 17, Issue 1 SUPPL., 2006, Pages

  Sinha, A M ^a   Breithardt, O A ^b  

^a KLINIKUM COBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

BNP; Cardiac resynchronization therapy; Heart failure; Neurohumoral parameters; Nt proBNP; Prognosis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NATRIURETIC FACTOR; NEUROHORMONE; SPIRONOLACTONE;

AMINO TERMINAL SEQUENCE; CARDIAC RESYNCHRONIZATION THERAPY; HEART FAILURE; HEART MUSCLE CONTRACTILE FORCE; HEMODYNAMIC MONITORING; HUMAN; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN SECRETION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT; SYMPATHETIC TONE;

ARRHYTHMIA; BIOLOGICAL MARKERS; CARDIAC PACING, ARTIFICIAL; HUMANS; NATRIURETIC PEPTIDES; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 33645681058     PISSN: 09387412     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00399-006-1108-6     Document Type: Review

References (27)

1. Abraham WT, Fisher WG, Smith AL et al for the MIRACLE Study Group (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845-1853
2. Anand IS, Fisher LD, Chiang YT et al (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107:1278-1283
3. Auricchio A, Stellbrink C, Block M, et al (1999) The effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 99:2993-3001
4. Breithardt OA, Sinha AM, Schwammenthal E et al (2003) Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 41:765-770
5. Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140-2150
6. Cleland JGF, Daubert JC, Erdmann E et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352-363
7. De Denus S, Pharand C, Williamson DR (2004) Brain natriuretic peptide in the management of heart failure. Chest 125:652-668
8. Erol-Yilmaz A, Verberne HJ, Schrama TA et al (2005) Cardiac resynchronization induces favorable neurohumoral changes. Pacing Clin Electrophysiol 28:304-310
9. Goetze JP, Christoffersen C, Perko M et al (2003) Increased cardiac BNP expression associated with myocardial ischemia. FASEB 17:1105-1107
10. Krüger S, Graf J, Kunz D et al (2002) Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 40:718-722
11. Kucher N, Printzen G, Goldhaber SZ (2003) Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 107:2545-2547
12. Lainchbury JG, Campbell E, Frampton EM et al (2003) Brain Natriuretic Peptide and N-Terminal Brain Natriuretic Peptide in the Diagnosis of Heart Failure in Patients With Acute Shortness of Breath. J Am Coll Cardiol 42:728-735
13. Levin ER, Gardner DG, Samson WK (1998) Natriuretic peptides. N Engl J Med 339:321-328
14. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M (1998) Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135: 825-832
15. Maisel AS, Koon J, Krishnaswamy P et al (2001) Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 141:367-374
16. Maisel AS, Krishnaswamy P, Nowak RM et al (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161-167
17. McCullough PA, Duc P, Omland T et al (2003) B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 41:571-579
18. Morrison LK, Harrison A, Krishnaswamy P et al (2002) Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung diseases in patients presenting with dyspnea. J Am Coll Cardiol 39:202-209
19. Mueller C, Scholer A, Laule-Kilian K et al (2004) Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350:647-654
20. Redfield MM, Rodeheffer RJ, Jacobsen SJ et al (2002) Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40:976-982
21. Sinha AM, Filzmaier K, Breithardt OA et al (2003) Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure. Am J Cardiol 91:755-758
22. Sinha AM, Filzmaier K, Kunz D et al (2003) Correlation of brain natriuretic peptide release, cardiopulmonary exercise testing and 6 minute walking test in patients with heart failure and cardiac resynchronization therapy. J Am Coll Cardiol 41:60 (Abstract)
23. Sinha AM, Breithardt OA, Skobel EC et al (2005) Long-term effects of cardiac resynchronization therapy on brain natriuretic peptide release and left ventricular function in patients with heart failure. Heart Rhythm 2:S100 (Abstract)
24. Sinha AM, Breithardt OA, Schmid M, Stellbrink C (2005) Brain natriuretic peptide release in cardiac surgery patients. Thorac Cardiovasc Surg 53:138-143
25. Stellbrink C, Breithardt OA, Franke A et al (2001) Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbance. J Am Coll Cardiol 38:1957-1965
26. Wang TJ, Larson MG, Levy D et al (2004) Impact of obesity on plasma natriuretic peptide levels. Circulation 109:594-600
27. Wieczorek SJ, Wu AH, Christenson R et al (2002) A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J 144:834-839